MGTX Q1 2026 Earnings Missed EPS Estimates as PreRevenue Biotech Advances Pipeline HTHT Q1 2026 Earnings Slight EPS Miss Amidst Modest Stock Decline NRXP Q1 2026 Earnings Revenueless Biotech Reports EPS Miss but Stock Surges 34 SHFS Q3 2024 Earnings Positive EPS Emerges Amid Limited Disclosure SherwinWilliams SHW Q1 2026 Earnings EPS Beat Amidst Steady Demand and Cost Discipline Diamond Hill Investment Group Q1 2025 Earnings Steady EPS Amid a Quiet Quarter